Semantic Scholar uses AI to extract papers important to this topic.
Abstract Objective: This retrospective cohort study compared exacerbations, health services utilization, and costs among chronic… Expand BACKGROUND: Arformoterol tartrate (arformoterol, 15 μg bid) is a nebulized long-acting β2-agonist approved for maintenance… Expand Background Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent a significant economic burden… Expand Chronic obstructive pulmonary disease (COPD) is a serious global health burden. Comprehensive management of COPD includes both… Expand Some basic scientific data suggest that (S)-enantiomers of β2-agonists have different and sometimes opposing effects to (R… Expand BACKGROUND
Arformoterol is a single-isomer (R,R-formoterol) nebulized long-acting beta(2)-agonist approved for use in patients… Expand OBJECTIVE
The aim of this study was to assess the efficacy and tolerability of nebulized arformoterol tartrate (a selective, long… Expand ABSTRACT Objective: Arformoterol tartrate inhalation solution (15 μg/2 mL) is approved for the twice-daily, long-term maintenance… Expand β 2 -Adrenoceptor agonists are widely used as adjuncts to corticosteroids for the treatment of chronic obstructive pulmonary… Expand Arformoterol: (R,R)-eformoterol, (R,R)-formoterol, arformoterol tartrate, eformoterol-sepracor, formoterol-sepracor, R,R-eformoterol, R,R-formoterol. Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the beta(2)-adrenoceptor agonist… Expand